✦ LIBER ✦

Inappropriate Rate Response of the Minute Ventilation Rate Responsive Pacemaker in a Patient with Cheyne-Stokes Dyspnea

✍ Scribed by Patrice Scanu; Danièle Guilleman; Gilles Grollier; Jean-Claude Potier

Book ID: 109187594
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 60 KB
Volume: 12
Category: Article
ISSN: 0147-8389
DOI: 10.1111/j.1540-8159.1989.tb01891.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Echocardiography Induced Tachycardia in

Echocardiography Induced Tachycardia in a Patient with a Minute Ventilation Rate Responsive Pacemaker

✍ Chotikorn Khunnawat; Siddharth Mukerji; Sundar Sankaran; Ranjan K. Thakur 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Wide QRS Complex Tachycardia in a Patien

Wide QRS Complex Tachycardia in a Patient with a Minute Ventilation Rate-Responsive Pacemaker

✍ SIDDHARTH MUKERJI; CHOTIKORN KHUNNAWAT; SUNDAR SANKARAN; RANJAN K. THAKUR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

The value of serial carcinoembryonic ant

The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. A Southwest oncology group study

✍ Muhyi Al-Sarraf; Laurence Baker; Robert W. Talley; Karel Kithier; Vainutis K. Va 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB 👁 3 views

The addition of rituximab to front-line

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

✍ Buske, C; Hoster, E; Dreyling, M; Eimermacher, H; Wandt, H; Metzner, B; Fuchs, R 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 231 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB